DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated

H Christian Reinhardt1, Pia Hasskamp, Ingolf Schmedding

  • 1David H. Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02132, USA.

Molecular Cell
|October 12, 2010
PubMed

Insights

Cancer cells with defective p53 rely on the p38/MK2 pathway for DNA damage survival. This pathway maintains cell cycle arrest by stabilizing specific mRNAs, crucial for DNA repair.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Genotoxic stress triggers cellular responses including cell cycle arrest and DNA repair via kinase signaling.
  • p53-defective tumors exhibit altered DNA damage responses, becoming dependent on the p38/MK2 pathway for survival.
  • The ATR-Chk1 pathway is functional in these cells, yet checkpoint control is rewired.

Purpose of the Study:

  • To elucidate the distinct roles of Chk1 and MK2 in DNA damage checkpoint control using functional genetics.
  • To understand the molecular mechanisms underlying the p38/MK2 pathway's contribution to cancer cell survival post-DNA damage.

Main Methods:

  • Functional genetics to investigate Chk1 and MK2 functions.
  • Analysis of protein complex relocalization (p38/MK2) from nucleus to cytoplasm.
  • Assessment of mRNA stabilization and degradation pathways (Gadd45α mRNA).
  • Investigation of protein-protein interactions and phosphorylations (hnRNPA0, TIAR, PARN).

Main Results:

  • Nuclear Chk1 activity is essential for establishing the G(2)/M checkpoint.
  • Cytoplasmic MK2 activity is critical for prolonged checkpoint maintenance via posttranscriptional mRNA stabilization.
  • p38/MK2 complex relocalizes to the cytoplasm upon DNA damage.
  • MK2 stabilizes Gadd45α mRNA by phosphorylating hnRNPA0 and PARN, while p38 releases TIAR.
  • Gadd45α sustains a positive feedback loop, sequestering Cdc25B/C in the cytoplasm to prevent mitotic entry.

Conclusions:

  • The p38/MK2 pathway plays a critical role in the posttranscriptional regulation of gene expression during the DNA damage response in cancer cells.
  • Cytoplasmic MK2 activity is key for maintaining prolonged cell cycle arrest through mRNA stabilization.
  • This pathway represents a potential therapeutic target in p53-defective cancers.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...